Carnosic Acid
CAS 3650-09-7
Carnosic Acid (CAS 3650-09-7) is a pharmaceutical compound with 8 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 19300.49517857143 nM | 56 | - |
| - | Potency | 13235.58888888889 nM | 18 | - |
| - | IC50 | 27071.4375 nM | 16 | - |
| - | Ki | 4962 nM | 7 | - |
| - | EC50 | 65333.333333333336 nM | 3 | - |
| - | MIC | 2.6666666666666665 ug.mL-1 | 3 | - |
| - | IC50 | 12 ug.mL-1 | 1 | - |
| - | Kd | 20000 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Carnosic Acid used for in pharmaceutical contexts?
Carnosic Acid (CAS 3650-09-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Carnosic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Carnosic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Carnosic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Carnosic Acid with EU status "permitted".
What clinical phase is Carnosic Acid in?
No phase 1-4 clinical development badge is rendered for Carnosic Acid because the matched compound identifier rows do not contain a max-phase value.